Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesPreferred Dividend PaymentsProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Organogenesis Holdings (ORGO) Income from Continuing Operations (2016 - 2025)

Organogenesis Holdings has reported Income from Continuing Operations over the past 10 years, most recently at 53200000.0 for Q4 2025.

  • Quarterly results put Income from Continuing Operations at 53200000.0 for Q4 2025, up 593.34% from a year ago — trailing twelve months through Dec 2025 was 46532000.0 (up 5304.41% YoY), and the annual figure for FY2025 was 46532000.0, up 5304.41%.
  • Income from Continuing Operations for Q4 2025 was 53200000.0 at Organogenesis Holdings, up from 21567000.0 in the prior quarter.
  • Over the last five years, Income from Continuing Operations for ORGO hit a ceiling of 53200000.0 in Q4 2025 and a floor of 18843000.0 in Q1 2025.
  • Median Income from Continuing Operations over the past 5 years was 6494500.0 (2023), compared with a mean of 8202650.0.
  • Biggest five-year swings in Income from Continuing Operations: skyrocketed 1450.88% in 2024 and later crashed 797.29% in 2025.
  • Organogenesis Holdings' Income from Continuing Operations stood at 50995000.0 in 2021, then crashed by 81.44% to 9466000.0 in 2022, then plummeted by 106.0% to 568000.0 in 2023, then skyrocketed by 1450.88% to 7673000.0 in 2024, then soared by 593.34% to 53200000.0 in 2025.
  • The last three reported values for Income from Continuing Operations were 53200000.0 (Q4 2025), 21567000.0 (Q3 2025), and 9392000.0 (Q2 2025) per Business Quant data.